GUARD.ST Net Margin

The Net Margin of Guard Therapeutics International AB (publ) (GUARD.ST) is -42396.97%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

GUARD.ST Net Margin - Historical Value

Date	Value
2024-12-31	-42396.97%

GUARD.ST Net Margin - Peers Comparison

Ticker	Name	Value
ATORX.ST	Alligator Bioscience AB	-404.89%
BIOA B.ST	BioArctic AB	-68.81%
GV.PA	Genomic Vision SA	-661.79%
SPRINT.ST	Sprint Bioscience AB	-27.84%
ALLR.ST	Allarity Therapeutics A/S	-16473.80%
ALZ.ST	Alzinova AB	-68510.00%
ALPRE.PA	Predilife SA	-1329.21%
VITR.ST	Vitrolife AB	14.21%
COMBI.ST	Combigene AB	-13766.26%
GEN.WA	Genomed SA	4.82%
IMMU.ST	Mendus AB (publ)	-7736.06%
LIDDS.ST	Lidds AB	-1952.33%
MTPH.L	Midatech Pharma PLC	-944.64%
ABNX.PA	Abionyx Pharma SA	-95.24%
BONEX.ST	Bonesupport Holding AB	14.88%
VAL.L	ValiRx PLC	-21226.04%
BIOG B.ST	Biogaia AB	24.70%
ISR.ST	ISR Immune System Regulation Holding AB (publ)	-52301.14%
ACTI.ST	Active Biotech AB publ	-479.48%
ALPAT.PA	Plant Advanced Technologies PAT SA	4.71%
EVG.L	Evgen Pharma PLC	-914.71%
PROB.ST	Probi AB	2.68%
SCS.WA	Stem Cells Spin SA	-36.81%
AEGIR.ST	Aegirbio AB	-64886.96%
ALNEV.PA	Neovacs SA	-1639.16%
IVACC.ST	Intervacc AB	-640.66%
MVIR B.ST	Medivir AB	-2018.18%
PROMO.ST	Promore Pharma AB	-148733.33%
XINT.ST	Xintela AB	-929.77%
ALNOX.PA	Noxxon Pharma NV	-12954.20%
HNSA.ST	Hansa Biopharma AB	-470.91%
SOBI.ST	Swedish Orphan Biovitrum AB (publ)	14.93%
TOL.ST	Toleranzia AB	-5871.43%
XBRANE.ST	Xbrane Biopharma AB	-133.97%
RDG.WA	Read Gene SA	-7.75%
SENZA.ST	SenzaGen AB	-30.94%